EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Boulos Asfour
Ehrenfried Schindler
Anne Marie Brecher
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinzobahamvya, N.
Right arrow Articles by Brecher, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinzobahamvya, N.
Right arrow Articles by Brecher, A. M.
Related Collections
Right arrow Congenital - cyanotic

Eur J Cardiothorac Surg 2007;32:209-214. doi:10.1016/j.ejcts.2007.04.036
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Compared fate of small-diameter Contegras® and homografts in the pulmonary position

Nicodème Sinzobahamvyaa,*, Boulos Asfoura, Margaretha Boscheinenb, Joachim Photiadisa, Christoph Finkc, Ehrenfried Schindlerd, Victor Hraskaa, Anne Marie Brechera

a Department of Pediatric Thoracic and Cardiovascular Surgery, Congenital Cardiac Center (‘Deutsches Kinderherzzentrum’), Sankt Augustin, Germany
b Department of Pediatric Cardiology, Congenital Cardiac Center (‘Deutsches Kinderherzzentrum’), Sankt Augustin, Germany
c Department of Cardiac Intensive Care, Congenital Cardiac Center (‘Deutsches Kinderherzzentrum’), Sankt Augustin, Germany
d Department of Anesthesiology and Critical Care Medicine, Congenital Cardiac Center (‘Deutsches Kinderherzzentrum’), Sankt Augustin, Germany

Received 16 February 2007; received in revised form 25 April 2007; accepted 30 April 2007.

* Corresponding author. Address: Deutsches Kinderherzzentrum, Asklepios Klinik, Arnold-Janssen-Strasse, 29 53757 Sankt Augustin, Germany. Tel.: +49 2241 249601; fax: +49 2241 249602. (Email: n.sinzobahamvya{at}asklepios.com).

Objective: This study analyzes whether small-diameter Contegras behave in the same way as small-diameter homografts, when implanted for the first time in pulmonary position. Methods: Small-diameter conduits include 12 and 14 mm Contegras and 8–14 mm homografts. Graft dysfunction is defined as right ventricular outflow tract obstruction with peak echo-Doppler gradient > 40 mmHg, or grade III/IV graft regurgitation. Graft failure is defined as need for conduit replacement or need for catheter or surgical reintervention. Thirty-eight patients who received small Contegras (n = 25) and small homografts (n = 13) from October 2002 to end December 2006 were studied. The most frequent indication was pulmonary atresia and ventricular septal defect (n = 20; 10 associated with major aorto-pulmonary collateral arteries), followed by truncus arteriosus (n = 12). Most patients’ characteristics were comparable except that recipients of homografts were smaller (p for body area = 0.014). Survival, freedom from graft dysfunction, failure and explantation were estimated by the Kaplan–Meier method. The log-rank test was used to compare outcomes. Results: There were three early and four late deaths. No death was graft related. Survival was 80 ± 8.2% for patients with Contegras and 77 ± 11.7% for those with allografts: p = 0.82. Mean follow-up duration is 22 ± 16 months. Freedom from dysfunction for Contegra conduits decreased in the first 6 months and stabilized at 58 ± 11% from month 14. For homografts it decreased only 1 year after implantation, down to 35 ± 19.7% from month 31: p = 0.61. Freedom from Contegra failure diminished the first 16 months to level out at 57 ± 13%. No homograft failed the first 2 years. With a p-value of 0.14, homografts tended to fail less frequently. Five grafts were explanted. Freedom from explantation was similar (p = 0.98): 90 ± 6.7% for Contegras and 75 ± 21.6% for homografts at year 3. Conclusion: In the first 4 years after pulmonary implantation of small-diameter Contegras and homografts, the fate of both conduits was statistically similar, in spite of different behavior. As Contegra is ‘off-the-shelf’ available, it constitutes a sound alternative to homograft for right ventricular outflow tract reconstruction in neonates and infants.

Key Words: Valved conduits • Contegra • Homograft • Right ventricular outflow tract reconstruction




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
E. J. Hickey, B. W. McCrindle, E. H. Blackstone, T. Yeh Jr., F. Pigula, D. Clarke, C. I. Tchervenkov, J. Hawkins, and the CHSS Pulmonary Conduit Working Group
Jugular venous valved conduit (Contegra(R)) matches allograft performance in infant truncus arteriosus repair
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 890 - 898.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.